Global Anemia In Elderly Market, Global Anemia In Elderly Market Report, Global Anemia In Elderly Market Trends, Global Anemia In Elderly Market Size

Global Anemia In Elderly Market Size Projected to Reach $4.22 Billion During the Forecast Period

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Anemia In Elderly Market Expected To Expand Between 2025 And 2029?

The anemia in elderly market size has demonstrated robust growth in recent years. It is projected to expand from $2.75 billion in 2024 to $2.99 billion in 2025, showing a compound annual growth rate (CAGR) of 8.8%. This historical growth can be attributed to factors such as nutritional deficiencies, chronic diseases, inflammation, bone marrow disorders, and blood loss.

The anemia in elderly market size is poised for significant expansion over the next few years. It is forecast to reach $4.22 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is driven by an aging population, the increasing prevalence of chronic diseases, progress in diagnostic tools, heightened healthcare awareness, and improved access to treatment. Prominent trends expected in this period include AI-driven diagnostics, wearable health monitors, sophisticated blood analysis tools, the integration of telehealth, and personalized medicine solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Anemia In Elderly Industry?

The expanding elderly demographic is anticipated to stimulate the expansion of the anemia in the elderly market. This demographic refers to the rising count and proportion of individuals aged 65 and above, either within a specific society or globally. Its growth is largely attributable to factors such as longer life expectancies, decreasing birth rates, and the aging of large population groups. An increase in the elderly population consequently elevates the occurrence of age-related and chronic ailments, which are key contributors to anemia in older individuals. This, in turn, boosts the requirement for diagnosis, management, and treatment of anemia, thereby propelling market advancement. For example, the Office for National Statistics (ONS), a UK-based governmental body, reported in July 2024 that the population aged 65 or above in the UK grew from 11 million in 2021 to 12.7 million in 2022. Consequently, the expanding elderly population is a major factor in the growth of the anemia in the elderly market.

What Are The Major Segments Identified In The Anemia In Elderly Market?

The anemia in elderlymarket covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements; Vitamin B12 Supplements; Folic Acid Tablets; Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections; Vitamin B12 Injections; Erythropoiesis-Stimulating Agents (ESAs) Injections; Folic Acid Injections

How Are Trends Influencing The Anemia In Elderly Market?

Major companies operating in the anemia in the elderly market are concentrating on technological advancements, such as personalized therapies, to refine treatment processes, improve patient outcomes, reduce side effects, and enhance overall healthcare efficiency. Customized therapies are medical treatments designed based on each patient’s unique characteristics. For instance, in March 2024, Cadila Pharmaceuticals, an Indian-based pharmaceutical company, announced the introduction of Redshot FCM, a novel iron injection created to treat iron deficiency anemia for patients experiencing oral iron intolerance. This is an intravenous iron preparation that supplies adequate amounts of iron and boasts an exemplary safety profile. The injection utilizes an advanced Ferric Carboxymaltose formulation that improves iron delivery and absorption. Redshot FCM illustrates a dedication to enhancing healthcare by developing personalized therapies that consider individual patient profiles, leading to superior treatment outcomes for iron deficiency anemia.

Which Global Market Leaders Are Shaping The Future Of The Anemia In Elderly Sector?

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Which Geographies Are Emerging As Strong Markets For The Anemia In Elderly Industry?

North America was the largest region in the anemia in elderly market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Anemia In Elderly Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20711&type=smp

Browse Through More Reports Similar to the Global Anemia In Elderly Market 2025, By The Business Research Company

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Hematology Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/hematology-drugs-global-market

Chemotherapy Induced Anemia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795